First of all, we showed that the addition of anti-CD35 antibody and/or rCCL-5 (to compete for DARC) had no significant effects on HIV infection/replication in CD4+ T cells alone (see Fig. S5A and B in the supplemental material). Here, ACKR1 is linked to HIV infectious disease.